Dan M

/Dan Malowany

About Dan Malowany

This author has not yet filled in any details.
So far Dan Malowany has created 3 blog entries.

Corporate Citizenship, Expanded Access, and Ethical Pre-License Drug Sales

  Keith Watts Abstract High public expectations for corporate social responsibility (CSR) and accountability have directed pharmaceutical industry practices to influence positive change locally and globally. Drug companies often respond to issues affecting patient well-being following commercialization of new products. Today, pharmaceutical companies are held to higher standards as corporate citizens and must now consider how to implement this role throughout a [...]

By |2018-01-10T16:54:27+00:00December 20th, 2016|White Papers|0 Comments

Have you seen the new Opdivo Commercial?

Keith Watts. December 2016   Bristol-Myers Squibb (BMY) has created a very compelling commercial with a strong message that goes something like this: “Ask your doctor about Opdivo for a chance at a longer life.”[1] This is very encouraging for anyone who has run out of treatment alternatives and is fortunate enough to live in [...]

By |2018-01-24T22:28:45+00:00December 15th, 2016|News|0 Comments

The Patient Cannot Afford to Wait for FDA Approved Medication

Keith Watts. July 2016 I have spent the overwhelming majority of my professional life in the pharmaceutical industry.  I have watched, and to some degree engaged in the pharmaceutical industry’s evolution over many years.  It is my view that most pharmaceutical manufacturers are good corporate citizens.  Most of these companies have a decent track [...]

By |2018-01-24T22:31:07+00:00September 27th, 2016|News|0 Comments